The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pets Anti-infectives Market Research Report 2025
Synopsis
Pets anti-infectives are medications or products used to treat or prevent infections in pets, such as dogs and cats. These anti-infective agents are to target various pathogens, including bacteria, viruses, fungi, and parasites that cause infections in pets. They are available in different forms, such as oral medications, topical treatments, injections, and disinfectants for environmental use.
The global Pets Anti-infectives market was valued at US$ 1687 million in 2023 and is anticipated to reach US$ 2559 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
These medications are used to treat bacterial infections in pets. They can be categorized into different classes based on their mode of action and spectrum of activity. Common antibiotics for pets include penicillins, cephalosporins, fluoroquinolones, tetracyclines, and macrolides.These medications are used to treat fungal infections in pets. They are available in various forms, including oral medications, topical creams, and shampoos. Examples of antifungal agents for pets include azoles, such as fluconazole and ketoconazole.The use of anti-infectives for pets should be based on proper diagnosis and veterinary guidance. It's important to follow the dosage instructions and recommended treatment protocols. Additionally, maintaining good hygiene and cleanliness, along with regular veterinary check-ups, can help prevent and control infections in pets.
This report aims to provide a comprehensive presentation of the global market for Pets Anti-infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Anti-infectives.
Report Scope
The Pets Anti-infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pets Anti-infectives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets Anti-infectives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle
Segment by Type
Injection
Unguent
Segment by Application
Dogs
Cats
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pets Anti-infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pets Anti-infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pets anti-infectives are medications or products used to treat or prevent infections in pets, such as dogs and cats. These anti-infective agents are to target various pathogens, including bacteria, viruses, fungi, and parasites that cause infections in pets. They are available in different forms, such as oral medications, topical treatments, injections, and disinfectants for environmental use.
The global Pets Anti-infectives market was valued at US$ 1687 million in 2023 and is anticipated to reach US$ 2559 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
These medications are used to treat bacterial infections in pets. They can be categorized into different classes based on their mode of action and spectrum of activity. Common antibiotics for pets include penicillins, cephalosporins, fluoroquinolones, tetracyclines, and macrolides.These medications are used to treat fungal infections in pets. They are available in various forms, including oral medications, topical creams, and shampoos. Examples of antifungal agents for pets include azoles, such as fluconazole and ketoconazole.The use of anti-infectives for pets should be based on proper diagnosis and veterinary guidance. It's important to follow the dosage instructions and recommended treatment protocols. Additionally, maintaining good hygiene and cleanliness, along with regular veterinary check-ups, can help prevent and control infections in pets.
This report aims to provide a comprehensive presentation of the global market for Pets Anti-infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pets Anti-infectives.
Report Scope
The Pets Anti-infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pets Anti-infectives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pets Anti-infectives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Chanelle
Segment by Type
Injection
Unguent
Segment by Application
Dogs
Cats
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pets Anti-infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pets Anti-infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pets Anti-infectives Market Overview
1.1 Product Overview and Scope of Pets Anti-infectives
1.2 Pets Anti-infectives Segment by Type
1.2.1 Global Pets Anti-infectives Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Unguent
1.3 Pets Anti-infectives Segment by Application
1.3.1 Global Pets Anti-infectives Market Value by Application: (2024-2030)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Global Pets Anti-infectives Market Size Estimates and Forecasts
1.4.1 Global Pets Anti-infectives Revenue 2019-2030
1.4.2 Global Pets Anti-infectives Sales 2019-2030
1.4.3 Global Pets Anti-infectives Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pets Anti-infectives Market Competition by Manufacturers
2.1 Global Pets Anti-infectives Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pets Anti-infectives Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pets Anti-infectives Average Price by Manufacturers (2019-2024)
2.4 Global Pets Anti-infectives Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pets Anti-infectives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pets Anti-infectives, Product Type & Application
2.7 Pets Anti-infectives Market Competitive Situation and Trends
2.7.1 Pets Anti-infectives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pets Anti-infectives Players Market Share by Revenue
2.7.3 Global Pets Anti-infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pets Anti-infectives Retrospective Market Scenario by Region
3.1 Global Pets Anti-infectives Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pets Anti-infectives Global Pets Anti-infectives Sales by Region: 2019-2030
3.2.1 Global Pets Anti-infectives Sales by Region: 2019-2024
3.2.2 Global Pets Anti-infectives Sales by Region: 2025-2030
3.3 Global Pets Anti-infectives Global Pets Anti-infectives Revenue by Region: 2019-2030
3.3.1 Global Pets Anti-infectives Revenue by Region: 2019-2024
3.3.2 Global Pets Anti-infectives Revenue by Region: 2025-2030
3.4 North America Pets Anti-infectives Market Facts & Figures by Country
3.4.1 North America Pets Anti-infectives Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pets Anti-infectives Sales by Country (2019-2030)
3.4.3 North America Pets Anti-infectives Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pets Anti-infectives Market Facts & Figures by Country
3.5.1 Europe Pets Anti-infectives Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pets Anti-infectives Sales by Country (2019-2030)
3.5.3 Europe Pets Anti-infectives Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pets Anti-infectives Market Facts & Figures by Country
3.6.1 Asia Pacific Pets Anti-infectives Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pets Anti-infectives Sales by Country (2019-2030)
3.6.3 Asia Pacific Pets Anti-infectives Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pets Anti-infectives Market Facts & Figures by Country
3.7.1 Latin America Pets Anti-infectives Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pets Anti-infectives Sales by Country (2019-2030)
3.7.3 Latin America Pets Anti-infectives Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pets Anti-infectives Market Facts & Figures by Country
3.8.1 Middle East and Africa Pets Anti-infectives Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pets Anti-infectives Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pets Anti-infectives Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pets Anti-infectives Sales by Type (2019-2030)
4.1.1 Global Pets Anti-infectives Sales by Type (2019-2024)
4.1.2 Global Pets Anti-infectives Sales by Type (2025-2030)
4.1.3 Global Pets Anti-infectives Sales Market Share by Type (2019-2030)
4.2 Global Pets Anti-infectives Revenue by Type (2019-2030)
4.2.1 Global Pets Anti-infectives Revenue by Type (2019-2024)
4.2.2 Global Pets Anti-infectives Revenue by Type (2025-2030)
4.2.3 Global Pets Anti-infectives Revenue Market Share by Type (2019-2030)
4.3 Global Pets Anti-infectives Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pets Anti-infectives Sales by Application (2019-2030)
5.1.1 Global Pets Anti-infectives Sales by Application (2019-2024)
5.1.2 Global Pets Anti-infectives Sales by Application (2025-2030)
5.1.3 Global Pets Anti-infectives Sales Market Share by Application (2019-2030)
5.2 Global Pets Anti-infectives Revenue by Application (2019-2030)
5.2.1 Global Pets Anti-infectives Revenue by Application (2019-2024)
5.2.2 Global Pets Anti-infectives Revenue by Application (2025-2030)
5.2.3 Global Pets Anti-infectives Revenue Market Share by Application (2019-2030)
5.3 Global Pets Anti-infectives Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer Ingelheim Pets Anti-infectives Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Corporation Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zoetis Pets Anti-infectives Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Pets Anti-infectives Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Elanco
6.4.1 Elanco Corporation Information
6.4.2 Elanco Description and Business Overview
6.4.3 Elanco Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elanco Pets Anti-infectives Product Portfolio
6.4.5 Elanco Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bayer Pets Anti-infectives Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Virbac Pets Anti-infectives Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Ceva Sante Animale
6.6.1 Ceva Sante Animale Corporation Information
6.6.2 Ceva Sante Animale Description and Business Overview
6.6.3 Ceva Sante Animale Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Sante Animale Pets Anti-infectives Product Portfolio
6.7.5 Ceva Sante Animale Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Vetoquinol Pets Anti-infectives Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Bimeda Animal Health
6.9.1 Bimeda Animal Health Corporation Information
6.9.2 Bimeda Animal Health Description and Business Overview
6.9.3 Bimeda Animal Health Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Bimeda Animal Health Pets Anti-infectives Product Portfolio
6.9.5 Bimeda Animal Health Recent Developments/Updates
6.10 Chanelle
6.10.1 Chanelle Corporation Information
6.10.2 Chanelle Description and Business Overview
6.10.3 Chanelle Pets Anti-infectives Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Chanelle Pets Anti-infectives Product Portfolio
6.10.5 Chanelle Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pets Anti-infectives Industry Chain Analysis
7.2 Pets Anti-infectives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pets Anti-infectives Production Mode & Process
7.4 Pets Anti-infectives Sales and Marketing
7.4.1 Pets Anti-infectives Sales Channels
7.4.2 Pets Anti-infectives Distributors
7.5 Pets Anti-infectives Customers
8 Pets Anti-infectives Market Dynamics
8.1 Pets Anti-infectives Industry Trends
8.2 Pets Anti-infectives Market Drivers
8.3 Pets Anti-infectives Market Challenges
8.4 Pets Anti-infectives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pets Anti-infectives Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pets Anti-infectives Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pets Anti-infectives Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pets Anti-infectives Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pets Anti-infectives Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pets Anti-infectives Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pets Anti-infectives Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pets Anti-infectives Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pets Anti-infectives, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pets Anti-infectives, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pets Anti-infectives, Product Type & Application
Table 12. Global Key Manufacturers of Pets Anti-infectives, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pets Anti-infectives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pets Anti-infectives as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pets Anti-infectives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pets Anti-infectives Sales by Region (2019-2024) & (K Units)
Table 18. Global Pets Anti-infectives Sales Market Share by Region (2019-2024)
Table 19. Global Pets Anti-infectives Sales by Region (2025-2030) & (K Units)
Table 20. Global Pets Anti-infectives Sales Market Share by Region (2025-2030)
Table 21. Global Pets Anti-infectives Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pets Anti-infectives Revenue Market Share by Region (2019-2024)
Table 23. Global Pets Anti-infectives Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pets Anti-infectives Revenue Market Share by Region (2025-2030)
Table 25. North America Pets Anti-infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pets Anti-infectives Sales by Country (2019-2024) & (K Units)
Table 27. North America Pets Anti-infectives Sales by Country (2025-2030) & (K Units)
Table 28. North America Pets Anti-infectives Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pets Anti-infectives Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pets Anti-infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pets Anti-infectives Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pets Anti-infectives Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pets Anti-infectives Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pets Anti-infectives Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pets Anti-infectives Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pets Anti-infectives Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pets Anti-infectives Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pets Anti-infectives Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pets Anti-infectives Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pets Anti-infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pets Anti-infectives Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pets Anti-infectives Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pets Anti-infectives Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pets Anti-infectives Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pets Anti-infectives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pets Anti-infectives Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Pets Anti-infectives Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Pets Anti-infectives Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pets Anti-infectives Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pets Anti-infectives Sales (K Units) by Type (2019-2024)
Table 51. Global Pets Anti-infectives Sales (K Units) by Type (2025-2030)
Table 52. Global Pets Anti-infectives Sales Market Share by Type (2019-2024)
Table 53. Global Pets Anti-infectives Sales Market Share by Type (2025-2030)
Table 54. Global Pets Anti-infectives Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pets Anti-infectives Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pets Anti-infectives Revenue Market Share by Type (2019-2024)
Table 57. Global Pets Anti-infectives Revenue Market Share by Type (2025-2030)
Table 58. Global Pets Anti-infectives Price (USD/Unit) by Type (2019-2024)
Table 59. Global Pets Anti-infectives Price (USD/Unit) by Type (2025-2030)
Table 60. Global Pets Anti-infectives Sales (K Units) by Application (2019-2024)
Table 61. Global Pets Anti-infectives Sales (K Units) by Application (2025-2030)
Table 62. Global Pets Anti-infectives Sales Market Share by Application (2019-2024)
Table 63. Global Pets Anti-infectives Sales Market Share by Application (2025-2030)
Table 64. Global Pets Anti-infectives Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pets Anti-infectives Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pets Anti-infectives Revenue Market Share by Application (2019-2024)
Table 67. Global Pets Anti-infectives Revenue Market Share by Application (2025-2030)
Table 68. Global Pets Anti-infectives Price (USD/Unit) by Application (2019-2024)
Table 69. Global Pets Anti-infectives Price (USD/Unit) by Application (2025-2030)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Boehringer Ingelheim Pets Anti-infectives Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Zoetis Corporation Information
Table 76. Zoetis Description and Business Overview
Table 77. Zoetis Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Zoetis Pets Anti-infectives Product
Table 79. Zoetis Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Merck Pets Anti-infectives Product
Table 84. Merck Recent Developments/Updates
Table 85. Elanco Corporation Information
Table 86. Elanco Description and Business Overview
Table 87. Elanco Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Elanco Pets Anti-infectives Product
Table 89. Elanco Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Bayer Pets Anti-infectives Product
Table 94. Bayer Recent Developments/Updates
Table 95. Virbac Corporation Information
Table 96. Virbac Description and Business Overview
Table 97. Virbac Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Virbac Pets Anti-infectives Product
Table 99. Virbac Recent Developments/Updates
Table 100. Ceva Sante Animale Corporation Information
Table 101. Ceva Sante Animale Description and Business Overview
Table 102. Ceva Sante Animale Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Ceva Sante Animale Pets Anti-infectives Product
Table 104. Ceva Sante Animale Recent Developments/Updates
Table 105. Vetoquinol Corporation Information
Table 106. Vetoquinol Description and Business Overview
Table 107. Vetoquinol Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Vetoquinol Pets Anti-infectives Product
Table 109. Vetoquinol Recent Developments/Updates
Table 110. Bimeda Animal Health Corporation Information
Table 111. Bimeda Animal Health Description and Business Overview
Table 112. Bimeda Animal Health Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Bimeda Animal Health Pets Anti-infectives Product
Table 114. Bimeda Animal Health Recent Developments/Updates
Table 115. Chanelle Corporation Information
Table 116. Chanelle Description and Business Overview
Table 117. Chanelle Pets Anti-infectives Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Chanelle Pets Anti-infectives Product
Table 119. Chanelle Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Pets Anti-infectives Distributors List
Table 123. Pets Anti-infectives Customers List
Table 124. Pets Anti-infectives Market Trends
Table 125. Pets Anti-infectives Market Drivers
Table 126. Pets Anti-infectives Market Challenges
Table 127. Pets Anti-infectives Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pets Anti-infectives
Figure 2. Global Pets Anti-infectives Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pets Anti-infectives Market Share by Type in 2023 & 2030
Figure 4. Injection Product Picture
Figure 5. Unguent Product Picture
Figure 6. Global Pets Anti-infectives Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pets Anti-infectives Market Share by Application in 2023 & 2030
Figure 8. Dogs
Figure 9. Cats
Figure 10. Other
Figure 11. Global Pets Anti-infectives Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pets Anti-infectives Market Size (2019-2030) & (US$ Million)
Figure 13. Global Pets Anti-infectives Sales (2019-2030) & (K Units)
Figure 14. Global Pets Anti-infectives Average Price (USD/Unit) & (2019-2030)
Figure 15. Pets Anti-infectives Report Years Considered
Figure 16. Pets Anti-infectives Sales Share by Manufacturers in 2023
Figure 17. Global Pets Anti-infectives Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Pets Anti-infectives Players: Market Share by Revenue in 2023
Figure 19. Pets Anti-infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Pets Anti-infectives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Pets Anti-infectives Sales Market Share by Country (2019-2030)
Figure 22. North America Pets Anti-infectives Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Pets Anti-infectives Sales Market Share by Country (2019-2030)
Figure 26. Europe Pets Anti-infectives Revenue Market Share by Country (2019-2030)
Figure 27. Germany Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Pets Anti-infectives Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Pets Anti-infectives Revenue Market Share by Region (2019-2030)
Figure 34. China Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Pets Anti-infectives Sales Market Share by Country (2019-2030)
Figure 45. Latin America Pets Anti-infectives Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Pets Anti-infectives Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Pets Anti-infectives Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Pets Anti-infectives Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Pets Anti-infectives by Type (2019-2030)
Figure 55. Global Revenue Market Share of Pets Anti-infectives by Type (2019-2030)
Figure 56. Global Pets Anti-infectives Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Pets Anti-infectives by Application (2019-2030)
Figure 58. Global Revenue Market Share of Pets Anti-infectives by Application (2019-2030)
Figure 59. Global Pets Anti-infectives Price (USD/Unit) by Application (2019-2030)
Figure 60. Pets Anti-infectives Value Chain
Figure 61. Pets Anti-infectives Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
